Author: Chi Heem Wong; Kien Wei Siah; Andrew W Lo
Title: Estimating Probabilities of Success of Clinical Trials for Vaccines and Other Anti-Infective Therapeutics Document date: 2020_4_14
ID: fnrm6a79_17
Snippet: Overall, 2,544 vaccine development programs are observed in our dataset, of which 1,838 are sponsored by industry and 706 do not involve any industry sponsor in any stage of development. For industry-sponsored drug development programs, 'respiratory infections' is the most actively researched vaccine category, comprising 34.8% (n=640) of all vaccine development programs (see Figure 2 ). Hepatitis B virus (HBV) and human immunodeficiency virus (HI.....
Document: Overall, 2,544 vaccine development programs are observed in our dataset, of which 1,838 are sponsored by industry and 706 do not involve any industry sponsor in any stage of development. For industry-sponsored drug development programs, 'respiratory infections' is the most actively researched vaccine category, comprising 34.8% (n=640) of all vaccine development programs (see Figure 2 ). Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) vaccines represent 11.6% (n=213) and 9.8% (n=181) of all vaccine development programs, respectively, whereas intra-abdominal infections, monkey pox, and severe acute respiratory syndrome (SARS) vaccines are the least researched fields, with only one development path observed per disease.
Search related documents:
Co phrase search for related documents- actively research and development stage: 1
- actively research and drug development: 1
- actively research and human immunodeficiency: 1
- actively research and human immunodeficiency virus: 1
- actively research and research field: 1, 2, 3, 4
- actively research and respiratory infection: 1, 2
- actively research and respiratory syndrome: 1, 2
- actively research and SARS vaccine: 1, 2
- actively research and severe acute respiratory syndrome: 1, 2
- actively research and vaccine development: 1
- acute respiratory syndrome and development path: 1, 2, 3, 4
- acute respiratory syndrome and development stage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- acute respiratory syndrome and disease observe: 1, 2, 3, 4
- acute respiratory syndrome and drug development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute respiratory syndrome and HIV human immunodeficiency virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- acute respiratory syndrome and HIV human immunodeficiency virus vaccine: 1, 2, 3, 4
- acute respiratory syndrome and human immunodeficiency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- acute respiratory syndrome and human immunodeficiency virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- acute respiratory syndrome and monkey pox: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date